Skip to main content
Emergency Medicine Journal : EMJ logoLink to Emergency Medicine Journal : EMJ
. 2005 Aug;22(8):582–585. doi: 10.1136/emj.2004.020271

Retrospective observational case-control study comparing prehospital thrombolytic therapy for ST-elevation myocardial infarction with in-hospital thrombolytic therapy for patients from same area

M Chittari 1, I Ahmad 1, B Chambers 1, F Knight 1, A Scriven 1, D Pitcher 1
PMCID: PMC1726897  PMID: 16046765

Abstract

Design: Retrospective observational case-control study comparing patients with suspected acute myocardial infarction (AMI) treated with thrombolytic therapy in the prehospital environment with patients treated in hospital.

Setting: Wyre Forest District and Worcestershire Royal Hospital, UK.

Participants: (A) All patients who received prehospital thrombolytic therapy for suspected AMI accompanied by electrocardiographic features considered diagnostic.

(B) Patients who received thrombolytic therapy after arrival at hospital for the same indication, matched with group A by age, gender and postcode.

Main outcome measures:

1. Call to needle time

2. Percentage of patients treated within one hour of calling for medical help

3. Appropriateness of thrombolytic therapy

4. Safety of thrombolytic therapy

Results: 1. The median call to needle time for patients treated before arriving in hospital (n = 27) was 40 minutes with an inter-quartile range 25–112 (mean 43 minutes). Patients from the same area who were treated in hospital (n = 27) had a median time of 106 minutes with an inter-quartile range 50–285 (mean 126 minutes). This represents a median time saved by prehospital treatment of 66 minutes.

2. 60 minutes after medical contact, 96 % of patients treated before arrival in hospital had received thrombolytic therapy; this compares with 4% of patients from similar areas treated in hospital.

3. Myocardial infarction was confirmed in 92% (25/27) of patients who received prehospital thrombolytic therapy and similarly 92% (25/27) of those given in-hospital thrombolytic therapy.

4. No major bleeding occurred in either group. Group A suffered fewer in-hospital deaths than group B (1 versus 4). Cardiogenic shock (3 patients) and ventricular arrhythmia (5 patients) were seen only in group B.

Conclusion: Paramedic-delivered thrombolytic therapy can be delivered appropriately, safely, and effectively. Time gains are substantial and can meet the national targets for early thrombolytic therapy in the majority of patients.

Full Text

The Full Text of this article is available as a PDF (61.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Applebaum D., Weiss A. T., Koren G., Ben David Y., Hasin Y., Gotsman M. S. Feasibility of pre-hospital fibrinolytic therapy in acute myocardial infarction. Am J Emerg Med. 1986 May;4(3):201–204. doi: 10.1016/0735-6757(86)90065-3. [DOI] [PubMed] [Google Scholar]
  2. Barbash G. I., Roth A., Hod H., Miller H. I., Modan M., Rath S., Zahav Y. H., Shachar A., Basan S., Battler A. Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol. 1990 Aug 1;66(3):261–266. doi: 10.1016/0002-9149(90)90832-l. [DOI] [PubMed] [Google Scholar]
  3. Boersma E., Maas A. C., Deckers J. W., Simoons M. L. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet. 1996 Sep 21;348(9030):771–775. doi: 10.1016/S0140-6736(96)02514-7. [DOI] [PubMed] [Google Scholar]
  4. Bonnefoy Eric, Lapostolle Frédéric, Leizorovicz Alain, Steg Gabriel, McFadden Eugène P., Dubien Pierre Yves, Cattan Simon, Boullenger Eric, Machecourt Jacques, Lacroute Jean-Micel. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002 Sep 14;360(9336):825–829. doi: 10.1016/S0140-6736(02)09963-4. [DOI] [PubMed] [Google Scholar]
  5. Bossaert L. L., Demey H. E., Colemont L. J., Beaucourt L., Fierens H., Dirix L., Pintens H. Prehospital thrombolytic treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex. Crit Care Med. 1988 Sep;16(9):823–830. doi: 10.1097/00003246-198809000-00001. [DOI] [PubMed] [Google Scholar]
  6. Grines C. L., Browne K. F., Marco J., Rothbaum D., Stone G. W., O'Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G. C. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993 Mar 11;328(10):673–679. doi: 10.1056/NEJM199303113281001. [DOI] [PubMed] [Google Scholar]
  7. Keeling Phil, Hughes Debbie, Price Linnie, Shaw Steve, Barton Andy. Safety and feasibility of prehospital thrombolysis carried out by paramedics. BMJ. 2003 Jul 5;327(7405):27–28. doi: 10.1136/bmj.327.7405.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Koren G., Weiss A. T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M. H. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985 Nov 28;313(22):1384–1389. doi: 10.1056/NEJM198511283132204. [DOI] [PubMed] [Google Scholar]
  9. Morrison L. J., Verbeek P. R., McDonald A. C., Sawadsky B. V., Cook D. J. Mortality and prehospital thrombolysis for acute myocardial infarction: A meta-analysis. JAMA. 2000 May 24;283(20):2686–2692. doi: 10.1001/jama.283.20.2686. [DOI] [PubMed] [Google Scholar]
  10. Pedley David K., Bissett Kim, Connolly Elizabeth M., Goodman Carol G., Golding Ian, Pringle T. H., McNeill G. P., Pringle S. D., Jones M. C. Prospective observational cohort study of time saved by prehospital thrombolysis for ST elevation myocardial infarction delivered by paramedics. BMJ. 2003 Jul 5;327(7405):22–26. doi: 10.1136/bmj.327.7405.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ross A. M., Coyne K. S., Reiner J. S., Greenhouse S. W., Fink C., Frey A., Moreyra E., Traboulsi M., Racine N., Riba A. L. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: the PACT trial. PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J Am Coll Cardiol. 1999 Dec;34(7):1954–1962. doi: 10.1016/s0735-1097(99)00444-1. [DOI] [PubMed] [Google Scholar]
  12. Roth A., Barbash G. I., Hod H., Miller H. I., Rath S., Modan M., Har-Zahav Y., Keren G., Bassan S., Kaplinsky E. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol. 1990 Apr;15(5):932–936. doi: 10.1016/0735-1097(90)90219-f. [DOI] [PubMed] [Google Scholar]
  13. Weaver W. D., Eisenberg M. S., Martin J. S., Litwin P. E., Shaeffer S. M., Ho M. T., Kudenchuk P., Hallstrom A. P., Cerqueira M. D., Copass M. K. Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. J Am Coll Cardiol. 1990 Apr;15(5):925–931. doi: 10.1016/0735-1097(90)90218-e. [DOI] [PubMed] [Google Scholar]
  14. Weiss A. T., Fine D. G., Applebaum D., Welber S., Sapoznikov D., Lotan C., Mosseri M., Hasin Y., Gotsman M. S. Prehospital coronary thrombolysis. A new strategy in acute myocardial infarction. Chest. 1987 Jul;92(1):124–128. doi: 10.1378/chest.92.1.124. [DOI] [PubMed] [Google Scholar]

Articles from Emergency Medicine Journal : EMJ are provided here courtesy of BMJ Publishing Group

RESOURCES